DRUCKEN

Univ.-Prof. Dr. Krishnaraj Rajalingam

Krishna received his Masters in Life sciences (M.Sc) from Bharathidasan University, Thiruchirapalli, India and he moved to Germany to work with Profs. Thomas Rudel and Thomas Meyer at the Max Planck Institute for Infections Biology (MPIIB) in Berlin. After obtaining his PhD, he continued at MPIIB as a scientist before moving to MSZ at the University of Würzburg to start with his own group. He subsequently moved to Frankfurt and was heading an Emmy Noether Group of the DFG at the Institute of Biochemistry II (IBCII), Goethe University. In 2013, he became a Senior group Leader and a PLUS3-Fellow of the Boehringer Ingelheim Foundation at the IBCII, Frankfurt. He is currently a Heisenberg professor in Cell biology (W3) and head of the Cell Biology unit at the Universitymedical center, Mainz. Since 2018, Krishna also holds a visiting research directorship at the IMCB, A*STAR Singapore. Krishna's scientific interests are in understanding the molecular signalling machinery controlling fundamental cellular processes like cell death/survival, migration and cellular differentiation.

Academic education


Scientific degrees

Professional career

Major Awards and Fellowships

International Patents

Prohibitin as a target for cancer therapy (PCT/EP2005/010339) (WO/2006/032528)

Flavaglines as inhibitors of KRAS oncogene 

Selected Publications